AMTM AMTM
Company Profile ↓Company Overview
AMTM (AMTM) is a publicly traded company listed on with a market capitalization of $5.70B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Revenue has grown at a 23.3% CAGR over the past five years.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Oct 2025 Revenue of $14.39B (+71.6% YoY); net profit $66.00M.
- Trailing 12 Months Year-on-year growth — revenue +71.6%.
- 5-Year Trend Long-term compounding — revenue CAGR 23.3%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 23.31% |
| 1 Year: | 71.59% |
Stock Price Performance
| 1 Year: | -4.41% |
| 6 Months: | -35.38% |
| 3 Months: | -3.78% |
| 1 Month: | +10.48% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMABelow
- RSI (14)58.97 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 23.3% over 5 years.
- Generates positive free cash flow.
CONS
- Trading at a high P/E of 86.7.
- Trading 37.6% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Dec 2023 | Mar 2024 | Jun 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Jan 2026 | Mar 2026 | Apr 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.98B | 2.05B | 2.14B | 3.42B | 3.49B | 3.56B | 3.92B | 3.24B | 3.24B | 3.48B | 3.48B |
| Cost of Revenue | - | - | - | - | 3.12B | 3.19B | 3.51B | 2.91B | - | 3.13B | - |
| Gross Profit | - | - | - | - | 367.00M | 368.00M | 417.00M | 326.00M | - | 345.00M | - |
| Operating Expenses | - | - | - | - | 265.00M | 283.00M | 297.00M | 209.00M | - | 218.00M | - |
| Operating Income | 86.00M | 89.00M | 89.00M | 132.00M | 102.00M | 85.00M | 120.00M | 117.00M | 138.00M | 127.00M | 151.00M |
| EBITDA | - | - | - | - | 239.00M | 229.00M | 258.00M | 244.00M | - | 251.00M | - |
| Interest Expense | - | - | - | - | 86.00M | 88.00M | 92.00M | 74.00M | - | 73.00M | - |
| Pretax Income | - | - | - | - | 24.00M | 12.00M | 34.00M | 64.00M | - | 78.00M | - |
| Tax Provision | - | - | - | - | 22.00M | 13.00M | -3.00M | 20.00M | - | 24.00M | - |
| Net Income | -41.00M | -41.00M | -26.00M | 12.00M | 4.00M | 10.00M | 40.00M | 44.00M | 44.00M | 54.00M | 54.00M |
| Diluted EPS | -0.46 | -0.46 | -0.29 | 0.05 | 0.02 | 0.04 | 0.16 | 0.18 | 0.18 | 0.22 | 0.22 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Sep 2022 | Sep 2023 | Sep 2024 | Oct 2025 |
|---|---|---|---|---|
| Revenue | 7.68B | 7.87B | 8.39B | 14.39B |
| Operating Income | 121.00M | 57.00M | 291.00M | 480.00M |
| Net Income | -84.00M | -314.00M | -82.00M | 66.00M |
| Diluted EPS | -0.93 | -3.49 | -0.90 | 0.27 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Oct 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 | Oct 2025 |
|---|---|---|---|---|---|---|
| Total Assets | - | 4.22B | 6.41B | 11.97B | 11.46B | 11.46B |
| Current Assets | - | 1.36B | 1.93B | 3.08B | 3.11B | - |
| Cash & Equivalents | - | 207.00M | 305.00M | 452.00M | 437.00M | 437.00M |
| Inventory | - | - | - | - | - | - |
| Receivables | - | 368.00M | 1.44B | 2.40B | 2.48B | - |
| Total Liabilities | - | 919.00M | 6.00B | 7.42B | 6.84B | 6.84B |
| Current Liabilities | - | 713.00M | 1.38B | 1.97B | 2.35B | 2.35B |
| Long Term Debt | - | - | 4.07B | 4.64B | 3.90B | 3.90B |
| Total Debt | - | 121.00M | 4.33B | 4.94B | 4.17B | - |
| Total Equity | 822.00M | 3.26B | 375.00M | 4.46B | 4.50B | 4.50B |
| Shares Outstanding | - | 153.28M | 153.28M | 243.30M | 243.46M | - |
Cash Flows (Annual)
Figures in USD.
| Metric | Sep 2022 | Sep 2023 | Sep 2024 | Oct 2025 |
|---|---|---|---|---|
| Operating Cash Flow | 126.00M | 67.00M | 47.00M | 543.00M |
| Investing Cash Flow | -1.79B | -17.00M | 475.00M | 228.00M |
| Financing Cash Flow | 1.72B | -112.00M | -382.00M | -790.00M |
| Capital Expenditure | -18.00M | -12.00M | -11.00M | -27.00M |
| Free Cash Flow | 108.00M | 55.00M | 36.00M | 516.00M |
Ratios (Annual)
Figures in %.
| Metric | Sep 2022 | Sep 2023 | Sep 2024 | Oct 2025 |
|---|---|---|---|---|
| Gross Margin % | - | - | - | - |
| Operating Margin % | 1.6% | 0.7% | 3.5% | 3.3% |
| Net Margin % | -1.1% | -4.0% | -1.0% | 0.5% |
| ROE % | -2.6% | -83.7% | -1.8% | 1.5% |
| ROCE % | 3.5% | 1.1% | 2.9% | 5.3% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for AMTM
Amentum Holdings (AMTM) After Earnings Hopes And Nuclear Deal Is The Stock Already Priced In - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi4AFBVV95cUxPOTRCUDRfRkQtSXpSNEpVd1pMNkpvM2dfLWcxVXpSMzF3YnFNT3BFdmt5bHE2VW9GNHdiWUpHMjdheGsyeUxyaGlmUG5zUHh2U1BwRTBpaHltWlVvOGtkOV8yRklOeDFJT2F2ekFUcXVpa2cxTlExNU40ZjVQM3VwYkVQWnZPaTdyb0ZITV…
Amentum Holdings Inc. stock falls Wednesday, underperforms market - MarketWatch
<a href="https://news.google.com/rss/articles/CBMi2AFBVV95cUxNVEZCZVROMnZUZHFGR1MxYzNCcE5LTTVJbG5kUVdUODY5bzN6eEpWR1NLMVo0ODRMQi1DME9NZjdHc1ZxRDg4bTNkTU5KX3hxZXBubUE2NnluSlpDNUpTRkQ2UHFhXzJSYXNGY3FnQ2lrNzVZa1ZMRndHbXM4QjlQSktyTEw3ODlDSksweV…
Amentum (AMTM) Stock May Look Fully Priced After NASA Contract Win - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxQX2hheEU2NnRGamhLcnFJdHl2Zm5NVzB0TjJ0WHRYNkJ6bEQ5WGs2WkJ2d19OVG03emd0NlJLMU1LSzl3MVlrYXV5ckhqYVpXZy1QeHZvems5U0dnRGk3MlNyNjhBWkQ3VG9kMmJYNUdBUGxQTWRDX1JuV1lOT1F2RHFabmppdkR0T2NYdm…
Amentum Joins Westinghouse on 1-Gigawatt Reactor Delivery - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxOWGQ2YWhqa1pvS29YZm9QRWZ1WHVPNnVrQU4xeGlGRGRRNEVNbXFKOC1yUUNfTU55eHFKVkJ4dF9mR2txTlB2S2diS0M2OFNFa1NfRDVzMjUxcG51Z0IzVGYyU2lrZFRWbFN1T0Q5emdib3d5QktSY253elhHaWVhRUZkZjRVQzJJRTZXZ2…
Top Amentum (AMTM) Competitors 2026 - MarketBeat
<a href="https://news.google.com/rss/articles/CBMifkFVX3lxTE90eThEVmFzQU5tMVBsVDB3U1lVVGpCaE1ibXY1Nk1mTHlVaUFGUmVYakxDSllUSzNEMTZjR0g5MVVFcnN2LUt5RkhvT3FJOUFvZlFjUkRpdHNxVjg4azUyTktHRnNjT1JqblhHcEdqbEdQTjJ3RTBNa2xpQXVHZw?oc=5" target="_blan…
Amentum Holdings Stock: Multiple Re-Rating Incoming (NYSE:AMTM) - Seeking Alpha
<a href="https://news.google.com/rss/articles/CBMiggFBVV95cUxPRDZDdktvQk03TFkxVHVUWlAwSGVmdXlPRDZYdVBjWmc1UUlIUFdFWTNPZzB2cW43VU5ySUlGT2ZubnRFTVJZaEo5R010eVhRSklyQkFwX2JBbG81a09ha01ENTA4X25uX0N6dmVBVWJSV09scDdfbHZCZm03cDRQbzZn?oc=5" target=…
AMTM — Frequently Asked Questions
What is the current share price of AMTM?
As of 2026-08-05 17:25 PDT, AMTM trades at $23.40 on NASDAQ/NYSE. Its 52-week range is $20.09 to $37.53.
What is the market capitalisation of AMTM?
AMTM has a market capitalisation of $5.70B on NASDAQ/NYSE.
What is the P/E ratio of AMTM?
AMTM trades at a trailing price-to-earnings (P/E) ratio of 86.67. Its price-to-book (P/B) ratio is 1.26.
What is the return on equity (ROE) of AMTM?
AMTM has a return on equity (ROE) of 1.47%. Its return on capital employed (ROCE) is 5.27%.
Is AMTM a good stock to buy?
This page provides a data-driven analysis of AMTM, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.